Content area
Full Text
Sahajanand Medical Technologies (SMT) announces a strategic partnership with Cordis, Cardinal Health's interventional vascular business.
The new partnership with SMT in India will provide Cardinal Health access to the fast-growing Indian cardiology market, as the latter marks its entry into the Indian market. SMT has a strong and established sales and direct distribution network across India including tier II & III cities. Through this partnership, the Cordis range of products would be made available to patients across the country.
According to the Global Burden of Disease study, nearly a quarter (24.8 per cent) of all deaths in India...